GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,092,000 | +170.6% | 265,681 | +26.9% | 0.01% | +175.0% |
| Q2 2022 | $6,687,000 | +5.8% | 209,310 | +14.8% | 0.00% | +33.3% |
| Q1 2022 | $6,319,000 | -29.6% | 182,404 | -40.5% | 0.00% | -25.0% |
| Q4 2021 | $8,978,000 | +8.3% | 306,708 | -5.7% | 0.00% | 0.0% |
| Q3 2021 | $8,290,000 | -37.9% | 325,367 | -14.6% | 0.00% | -33.3% |
| Q2 2021 | $13,343,000 | +2.0% | 381,004 | +18.6% | 0.01% | -14.3% |
| Q1 2021 | $13,087,000 | +15.7% | 321,155 | +22.9% | 0.01% | 0.0% |
| Q4 2020 | $11,315,000 | +20.6% | 261,261 | +53.6% | 0.01% | +16.7% |
| Q3 2020 | $9,380,000 | +40.1% | 170,110 | +60.4% | 0.01% | +20.0% |
| Q2 2020 | $6,694,000 | +38.9% | 106,036 | +12.4% | 0.01% | +25.0% |
| Q1 2020 | $4,819,000 | -38.6% | 94,329 | -4.4% | 0.00% | -20.0% |
| Q4 2019 | $7,845,000 | +495.7% | 98,704 | +263.1% | 0.01% | +400.0% |
| Q3 2019 | $1,317,000 | -61.3% | 27,185 | -58.0% | 0.00% | -50.0% |
| Q2 2019 | $3,405,000 | +235.1% | 64,764 | +236.8% | 0.00% | +100.0% |
| Q1 2019 | $1,016,000 | -66.4% | 19,231 | -73.9% | 0.00% | -50.0% |
| Q4 2018 | $3,020,000 | -76.4% | 73,607 | -78.1% | 0.00% | -50.0% |
| Q3 2018 | $12,777,000 | +17.7% | 336,266 | +40.0% | 0.00% | +33.3% |
| Q2 2018 | $10,853,000 | -66.7% | 240,138 | -64.4% | 0.00% | -81.2% |
| Q1 2018 | $32,608,000 | +511.0% | 675,158 | +397.4% | 0.02% | +433.3% |
| Q4 2017 | $5,337,000 | -64.0% | 135,726 | -71.6% | 0.00% | -70.0% |
| Q3 2017 | $14,833,000 | +90.9% | 477,829 | +68.1% | 0.01% | +66.7% |
| Q2 2017 | $7,772,000 | +178.2% | 284,268 | +274.5% | 0.01% | +200.0% |
| Q1 2017 | $2,794,000 | +432.2% | 75,912 | +107.7% | 0.00% | – |
| Q4 2016 | $525,000 | -70.1% | 36,551 | -52.1% | 0.00% | -100.0% |
| Q3 2016 | $1,757,000 | +299.3% | 76,317 | +186.4% | 0.00% | – |
| Q2 2016 | $440,000 | +405.7% | 26,649 | +380.8% | 0.00% | – |
| Q1 2016 | $87,000 | -71.0% | 5,543 | -40.5% | 0.00% | – |
| Q4 2015 | $300,000 | +275.0% | 9,316 | +388.8% | 0.00% | – |
| Q3 2015 | $80,000 | – | 1,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |